Telesis Bio, Inc. (OTCMKTS:TBIO – Get Free Report)’s share price passed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $0.03 and traded as low as $0.01. Telesis Bio shares last traded at $0.01, with a volume of 100 shares.
Telesis Bio Stock Performance
The stock has a market cap of $18,000.00, a P/E ratio of -0.00 and a beta of 2.58. The firm’s fifty day simple moving average is $0.01 and its 200-day simple moving average is $0.03.
Telesis Bio Company Profile
Telesis Bio, Inc develops automated synthetic biology systems designed to help researchers create and test biological molecules more efficiently. Its technology is intended to streamline the design-build-test process by automating tasks that traditionally require multiple manual laboratory steps.
The company’s primary products include the BioXp automated benchtop platforms and related consumables, software, and application-specific kits. These systems support the on-demand synthesis and assembly of DNA, messenger RNA and other biological constructs for applications such as gene and cell therapy research, vaccine development, protein engineering, diagnostics and synthetic biology.
Telesis Bio was formerly known as Codex DNA and changed its corporate name in 2023.
Read More
- Five stocks we like better than Telesis Bio
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Receive News & Ratings for Telesis Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Telesis Bio and related companies with MarketBeat.com's FREE daily email newsletter.
-etf-logo-1200x675.png){kind=logo}
